February 12, 2019 /

Vamorolone Clinical Trials in Duchenne (January 2019)

Vamorolone Clinical Trials in Duchenne (January 2019)

On January 30, 2019, ReveraGen joined Parent Project Muscular Dystrophy for a webinar to provide the community with an overview of the vamorolone drug development program for Duchenne, including results showing improved muscle function in completed clinical trials in 48 Duchenne boys, and a description of an ongoing clinical trial of 120 Duchenne boys that is accepting new patients at 30 sites internationally.


Join Our Mailing List